Glycemic Response

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Tempus
TempusIL - Chicago
1 program
Continuous glucose monitoringN/A1 trial
Active Trials
NCT04881019Active Not RecruitingEst. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TempusContinuous glucose monitoring

Clinical Trials (1)

NCT04881019TempusContinuous glucose monitoring

PRediction Of Glycemic RESponse Study

Start: Jun 2021Est. completion: Dec 2025
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space